Literature DB >> 24490033

Memantine in the management of affective recurrences of bipolar disorders after the discontinuation of long-term lithium treatment: three case histories.

Giulia Serra1, Lavinia De Chiara1, Giovanni Manfredi1, Alexia E Koukopoulos1, Gabriele Sani2, Paolo Girardi2, Athanasios Koukopoulos3, Gino Serra4.   

Abstract

Entities:  

Year:  2014        PMID： 24490033      PMCID： PMC3896132          DOI： 10.1177/2045125313507737

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN： 2045-1253


× No keyword cloud information.
  11 in total

Review 1.  Maintenance treatment study designs in bipolar disorder: do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers?

Authors:  Frederick K Goodwin; Elizabeth A Whitham; S Nassir Ghaemi
Journal:  CNS Drugs       Date:  2011-10-01       Impact factor: 5.749

Review 2.  Acquired lithium resistance revisited: discontinuation-induced refractoriness versus tolerance.

Authors:  Robert M Post
Journal:  J Affect Disord       Date:  2011-12-07       Impact factor: 4.839

3.  Antimanic and mood-stabilizing effect of memantine as an augmenting agent in treatment-resistant bipolar disorder.

Authors:  Athanasios Koukopoulos; Daniela Reginaldi; Giulia Serra; Alexia Koukopoulos; Gabriele Sani; Gino Serra
Journal:  Bipolar Disord       Date:  2010-05       Impact factor: 6.744

4.  Antimanic and long-lasting mood stabilizing effect of memantine in bipolar I mood disorder: two case reports.

Authors:  Giulia Serra; Lavinia De Chiara; Athanasios Koukopoulos; Gino Serra
Journal:  J Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.153

5.  The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: findings from a 12-month naturalistic trial.

Authors:  Athanasios Koukopoulos; Giulia Serra; Alexia E Koukopoulos; Daniela Reginaldi; Gino Serra
Journal:  J Affect Disord       Date:  2011-10-24       Impact factor: 4.839

6.  Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications.

Authors:  R J Baldessarini; L Tondo; A C Viguera
Journal:  Bipolar Disord       Date:  1999-09       Impact factor: 6.744

7.  Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified.

Authors:  W Greil; N Kleindienst
Journal:  Int Clin Psychopharmacol       Date:  1999-09       Impact factor: 1.659

Review 8.  The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.

Authors:  Gabriele Sani; Giulia Serra; Giorgio D Kotzalidis; Silvia Romano; Stefano M Tamorri; Giovanni Manfredi; Matteo Caloro; C Ludovica Telesforo; Saverio S Caltagirone; Isabella Panaccione; Alessio Simonetti; Francesca Demontis; Gino Serra; Paolo Girardi
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

9.  Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study.

Authors:  Lars Vedel Kessing; Gunnar Hellmund; John R Geddes; Guy M Goodwin; Per Kragh Andersen
Journal:  Br J Psychiatry       Date:  2011-05-18       Impact factor: 9.319

10.  Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.

Authors:  John R Geddes; Guy M Goodwin; Jennifer Rendell; Jean-Michel Azorin; Andrea Cipriani; Michael J Ostacher; Richard Morriss; Nicola Alder; Ed Juszczak
Journal:  Lancet       Date:  2010-01-19       Impact factor: 79.321
View more
  6 in total

1.  Failure of memantine to "reverse" quinpirole-induced hypomotility.

Authors:  Francesca Demontis; Gino Serra
Journal:  World J Psychiatry       Date:  2016-06-22

Review 2.  Memantine: New prospective in bipolar disorder treatment.

Authors:  Giulia Serra; Francesca Demontis; Francesca Serra; Lavinia De Chiara; Andrea Spoto; Paolo Girardi; Giulio Vidotto; Gino Serra
Journal:  World J Psychiatry       Date:  2014-12-22

Review 3.  Management of obsessive-compulsive disorder comorbid with bipolar disorder.

Authors:  Firoz Kazhungil; E Mohandas
Journal:  Indian J Psychiatry       Date:  2016 Jul-Sep       Impact factor: 1.759

Review 4.  Antidepressant-induced Dopamine Receptor Dysregulation: A Valid Animal Model of Manic-Depressive Illness.

Authors:  Francesca Demontis; Francesca Serra; Gino Serra
Journal:  Curr Neuropharmacol       Date:  2017-04       Impact factor: 7.363

Review 5.  Possible Antidepressant Effects of Memantine-Systematic Review with a Case Study.

Authors:  Marek Krzystanek; Stanisław Surma; Artur Pałasz; Monika Romańczyk; Krzysztof Krysta
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-18

6.  Evaluation of the Effect of Memantine Supplementation in the Treatment of Acute Phase of Mania in Bipolar Disorder of Elderly Patients: A Double-blind Randomized Controlled Trial.

Authors:  Victoria Omranifard; Mohammad Javad Tarrahi; Shima Sharifi; Mojgan Karahmadi
Journal:  Adv Biomed Res       Date:  2018-11-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.